LEIDY CARABALLO GALVA

Concepts (25)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
998
0.710
Why?
Liver Neoplasms
2
2021
1387
0.640
Why?
Immunotherapy, Adoptive
2
2026
962
0.510
Why?
Immunotherapy
1
2020
765
0.430
Why?
Interleukin-18
1
2026
78
0.230
Why?
Natural Killer T-Cells
1
2026
95
0.220
Why?
Xenograft Model Antitumor Assays
2
2026
999
0.190
Why?
Glypicans
1
2021
40
0.180
Why?
T-Lymphocytes
2
2020
1790
0.170
Why?
alpha-Fetoproteins
1
2020
139
0.150
Why?
Cancer Vaccines
1
2020
191
0.140
Why?
Receptors, Antigen, T-Cell
1
2020
502
0.120
Why?
Antibodies, Monoclonal
1
2021
1010
0.120
Why?
Mice
3
2026
18482
0.080
Why?
Animals
3
2026
34404
0.060
Why?
Interleukin-15
1
2026
104
0.060
Why?
Cytotoxicity, Immunologic
1
2026
276
0.060
Why?
Humans
4
2026
131759
0.050
Why?
HLA-A2 Antigen
1
2020
26
0.040
Why?
Pyrophosphatases
1
2020
22
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
70
0.040
Why?
Cross Reactions
1
2020
187
0.040
Why?
Cell Line, Tumor
1
2026
3692
0.030
Why?
Lymphocyte Activation
1
2020
681
0.030
Why?
Cells, Cultured
1
2020
2969
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (25)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_